Mechanism of adenylate cyclase activation by the rat lung cytoplasmic factors.
Epinephrine, histamine and prostaglandin E1 stimulated adenylate cyclase activity in lung membranes and their stimulation of the enzyme activity was completely blocked by propranolol, metiamide and indomethacin, respectively. A partially-purified activator from the adult rat lung also enhanced adenylate cyclase activity in membranes. However, stimulation of adenylate cyclase by the rat lung activator was not abolished by the above receptor antagonists. Further, epinephrine, NaF and Gpp(NH)p stimulated adenylate cyclase activity rather readily, whereas stimulation of the enzyme activity by the lung activator was evident after an initial lag phase of 10 min. Also, the lung activator produced additive activation of adenylate cyclase with epinephrine, NaF and Gpp(NH)p. These results indicate that the lung activator potentiates adenylate cyclase activity in membranes by a mechanism independent from those known for epinephrine, NaF and Gpp(NH)p. Incubation of lung membranes for 30 min at 40 degrees C resulted in a loss of adenylate cyclase activation by NaF and Gpp(NH)p. Addition of the released proteins to the heat-treated membranes did not restore the enzyme response to these agonists. However, heat treatment of lung membranes in the presence of 2-mercaptoethanol or dithiothreitol prevented the loss of adenylate cyclase response to NaF and Gpp(NH)p. N-ethylmaleimide abolished adenylate cyclase activation by epinephrine, NaF, Gpp(NH)p and the lung activator. These results indicate that the sulfhydryl groups are important for adenylate cyclase function in rat lung membranes.
Nijjar
M S
MS
Department of Anatomy & Physiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Canada.
Chaudhary
K C
KC
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D003593:Cytoplasm / Q000737:chemistry / Q000201:enzymology / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects*; D004837:Epinephrine / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D007213:Indomethacin / Q000494:pharmacology; D008168:Lung / Q000737:chemistry / Q000201:enzymology*; D008297:Male; D008785:Metiamide / Q000494:pharmacology; D009363:Neoplasm Proteins / Q000737:chemistry* / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012969:Sodium Fluoride / Q000494:pharmacology
D009363:Neoplasm Proteins; D011458:Prostaglandins E; C053371:parathyroid hormone-like adenylate cyclase-stimulating protein, human; D006165:Guanylyl Imidodiphosphate; D008785:Metiamide; D006632:Histamine; D012969:Sodium Fluoride; D011433:Propranolol; D000262:Adenylyl Cyclases; D007213:Indomethacin; D004837:Epinephrine